123:HKEXNewton Resources Ltd Analysis
Data as of 2026-05-25 - not real-time
₩22,500.00
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Anapass, Inc. is trading near its recent high with technical signals showing mixed messages: the RSI is deep in overbought territory while the MACD remains bullish, suggesting short‑term momentum but also a heightened risk of pull‑back. Volume is increasing and the market sentiment index reads extreme greed, yet the 30‑day volatility is markedly high, indicating a choppy price environment.
Fundamentally, the company faces significant challenges – revenue has contracted sharply, operating margins are negative and free cash flow is in the red, making the current dividend payout appear unsustainable. However, the discounted cash flow model places fair value well above the current price, implying a potential undervaluation if the business can stabilize. Investors should weigh the strong technical upside against the weak earnings backdrop and elevated risk factors before deciding on positioning.
Fundamentally, the company faces significant challenges – revenue has contracted sharply, operating margins are negative and free cash flow is in the red, making the current dividend payout appear unsustainable. However, the discounted cash flow model places fair value well above the current price, implying a potential undervaluation if the business can stabilize. Investors should weigh the strong technical upside against the weak earnings backdrop and elevated risk factors before deciding on positioning.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- RSI in overbought zone
- Price approaching resistance
- High short‑term volatility
Medium Term
1–3 yearsPositive
Model confidence: 6/10
Key Factors
- DCF suggests price upside
- Bullish MACD momentum
- Increasing trading volume
Long Term
> 3 yearsCautious
Model confidence: 4/10
Key Factors
- Sustained revenue decline
- Negative operating cash flow
- Unsustainable dividend payout
Key Metrics & Analysis
Financial Health
Revenue Growth-42.90%
Profit Margin2.51%
ROE3.67%
ROA-0.12%
Debt/Equity11.26
Op. Cash Flow₩28.9B
Free Cash Flow₩-2123869568
Industry P/E39.5
Technical Analysis
TrendNeutral
RSI77.3
Support₩16,220.00
Resistance₩22,700.00
MA 20₩18,009.00
MA 50₩17,282.80
MA 200₩17,606.40
MACDBullish
VolumeIncreasing
Fear & Greed Index91.61
Valuation
Fair Value₩27,199.49
GradeUndervalued
TypeValue
Dividend Yield1.11%
Risk Assessment
Beta-0.05
Volatility64.66%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.